Posted on Sept. 17, 2020We are collaborating with FactCheck.org, a project of the Annenberg Public Policy Center of the University of Pennsylvania, in an effort to identify misinformation and to ensure news consumers get the facts. This story first appeared on FactCheck.org.A long-circulating, unsubstantiated claim about the origins of the novel coronavirus resurfaced in recent days after a paper published online purported that SARS-CoV-2 was created in a lab.The baseless claim which we first addressed in the early days of the pandemic was further amplified when Fox News host Tucker Carlson featured an interview with one of the authors of the paper on his show on Sept. 15.That segment was viewed on YouTube nearly 2 million times and that link alone was shared by more nearly 50,000 users on Facebook, according to CrowdTangle analytics data, where other popular posts also repeated the allegations.But experts say the new paper, which has not been peer-reviewed, does not prove that the virus was created in a lab.The paper was uploaded to an open-access website Sept. 14 and was published by the Rule of Law Society & Rule of Law Foundation two related entities in New York tied to Steve Bannon, a former adviser to President Donald Trump. Bannon is listed as the chair of the Rule of Law Society in a registration document filed last year with the state.The organizations are connected to a partnership forged by Bannon and Guo Wengui, an exiled Chinese businessman, that has been described as being based on their shared disdain for the Chinese government. Guo is wanted in China on charges of bribery and fraud allegations he has denied according to The New York Times. Bannon announced in November 2018 that Guo would be setting up a $100 million Rule of Law fund in part to aid Chinese dissidents and their families.Guos work in the U.S., including consulting services from Bannon, has drawn the interest of federal investigators, The Wall Street Journal has reported.Rossen Reports: Busting COVID-19 myths with experiments you can try at homeThe new paper attempts to make the case that the novel coronavirus couldnt have come from nature and instead may have been created by altering a previously discovered bat coronavirus. But several of its main points rest on faulty conclusions.One of the studys main claims is that the genomic sequence of SARS-CoV-2 is suspiciously similar to that of a bat coronavirus discovered by military laboratories in China and therefore indicates that another coronavirus was used to create the novel coronavirus.Kristian G. Andersen, a professor of immunology and microbiology at Scripps Research who has studied the origins of the virus, said of the claim on Twitter: This simply cant be true there are more than 3,500 nucleotide differences between SARS-CoV-2 and these viruses.And Dr. Stanley Perlman, a professor of microbiology and immunology at the University of Iowa who studies coronaviruses, told us in an email that the coronavirus referenced ZC45 is only 89% related to SARS-CoV-2. In virology terms, that is very distant.Perlman said it would be nearly impossible to make the reverse genetics system needed to manipulate the virus and changing its sequence to arrive at SARS-CoV-2 would be virtually impossible since it would not be known how to manipulate the virus.Nevertheless, Dr. Li-Meng Yan one of the authors of the new paper and a virologist who has claimed she fled China to reveal the truth about COVID-19 doubled down on Carlsons show. She alleged a cover-up by the Chinese government and the scientific community.The paper goes on to suggest that SARS-CoV-2 contains a unique furin-cleavage site in its Spike protein which is completely absent in this particular class of coronaviruses found in nature and that, therefore, the virus was engineered.Susan R. Weiss, a University of Pennsylvania professor of microbiology who researches coronaviruses, told us in an email that that makes no sense in terms of what we know about coronaviruses.Among murine coronavirus strains there are viruses with the furin site and strains without closely related strains closer than SARS-1 and SARS-2 yet they are all virulent, Weiss said. So this observation says nothing to me about the virus being engineered.A furin site is a short protein sequence that can be recognized and cut by other proteins.Perlman also said furin sites are found in many coronaviruses and finding it does not surprise us in the field.The paper also argues a conspiracy is afoot by claiming that scientific journals wont publish the alternative theory that the virus may have come from a research laboratory.I dont believe that, Weiss said. It is just that the data is not compelling. I dont know any CoV researchers that believe this at all. There is no way anyone could figure out how to make a virus behave like SARS-2 asymptomatic spread for thing.In March, Andersen and other scientists concluded in an article in Nature Medicine that the novel coronavirus is not a laboratory construct or a purposefully manipulated virus. The authors said that the virus likely originated in one of two ways: natural selection in an animal host before zoonotic transfer, meaning before the spread of disease from animals to humans, or natural selection in humans following zoonotic transfer.The Nature Medicine article did say it couldnt rule out an accidental laboratory release of the naturally occurring virus, but its authors said they do not believe that any type of laboratory-based scenario is plausible.The new, dubious paper attempts to discredit those findings by saying the Nature Medicine studys authors show signs of conflict of interests, raising further concerns on the credibility of this publication.The supposed support for that allegation: that one of the authors, Columbia Universitys Dr. W. Ian Lipkin, received an award from China for his work on public health there following the 2003 outbreak of the coronavirus that causes severe acute respiratory syndrome, or SARS.The new paper also references the curriculum vitae of another author Edward C. Holmes, a researcher at the University of Sydney in Australia which shows that he has collaborated with scientists and organizations in China.espite the online lies and malicious editing of my Wikipedia page, I have never received any funds from China, personal or research, and have no grants with Chinese scientists. I do have some honorary appointments there and a nice certificate though, Holmes wrote on Twitter. I do work closely with some Chinese scientists and as that directly led to the first release of the genome sequence that might just perhaps possibly be argued to be a good thing.Andersen also said that the allegation about the authors being conflicted was wrong. y lab has never received funding from China and we have no collaborations with Chinese investigators. I have no financial interests in China, he said in a tweet. All our analyses are scientific and unbiased.Its worth noting that collaborations between researchers in the U.S. and China arent uncommon. A recent study published in Higher Education found that U.S. research output between 2014 and 2018 would have dropped without Chinese partnerships while Chinas output would have grown regardless of work with the U.S. he findings demonstrate that the USA has more to lose than gain in cutting ties with China, its authors wrote.Public health officials have also suggested the virus originated in bats.The Centers for Disease Control and Prevention has said: The SARS-CoV-2 virus is a betacoronavirus, like MERS-CoV and SARS-CoV. All three of these viruses have their origins in bats. The sequences from U.S. patients are similar to the one that China initially posted, suggesting a likely single, recent emergence of this virus from an animal reservoir. However, the exact source of this virus is unknown.And in April, the Office of the Director of National Intelligence said in a statement that the Intelligence Community also concurs with the wide scientific consensus that the COVID-19 virus was not manmade or genetically modified. The intelligence community, it said, will continue to rigorously examine emerging information and intelligence to determine whether the outbreak began through contact with infected animals or if it was the result of an accident at a laboratory in Wuhan.Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told National Geographic in a May interview, If you look at the evolution of the virus in bats and whats out there now, is very, very strongly leaning toward this could not have been artificially or deliberately manipulated.Everything about the stepwise evolution over time strongly indicates that evolved in nature and then jumped species, Fauci said.Jessica McDonald contributed to this article.Editors note: FactCheck.org is one of several organizations working with Facebook to debunk misinformation shared on social media. Our previous stories can be found here.
Posted on Sept. 17, 2020
We are collaborating with FactCheck.org, a project of the Annenberg Public Policy Center of the University of Pennsylvania, in an effort to identify misinformation and to ensure news consumers get the facts. This story first appeared on FactCheck.org.
A long-circulating, unsubstantiated claim about the origins of the novel coronavirus resurfaced in recent days after a paper published online purported that SARS-CoV-2 was created in a lab.
The baseless claim which we first addressed in the early days of the pandemic was further amplified when Fox News host Tucker Carlson featured an interview with one of the authors of the paper on his show on Sept. 15.
That segment was viewed on YouTube nearly 2 million times and that link alone was shared by more nearly 50,000 users on Facebook, according to CrowdTangle analytics data, where other popular posts also repeated the allegations.
But experts say the new paper, which has not been peer-reviewed, does not prove that the virus was created in a lab.
The paper was uploaded to an open-access website Sept. 14 and was published by the Rule of Law Society & Rule of Law Foundation two related entities in New York tied to Steve Bannon, a former adviser to President Donald Trump. Bannon is listed as the chair of the Rule of Law Society in a registration document filed last year with the state.
The organizations are connected to a partnership forged by Bannon and Guo Wengui, an exiled Chinese businessman, that has been described as being based on their shared disdain for the Chinese government. Guo is wanted in China on charges of bribery and fraud allegations he has denied according to The New York Times. Bannon announced in November 2018 that Guo would be setting up a $100 million Rule of Law fund in part to aid Chinese dissidents and their families.
Guos work in the U.S., including consulting services from Bannon, has drawn the interest of federal investigators, The Wall Street Journal has reported.
Rossen Reports: Busting COVID-19 myths with experiments you can try at home
The new paper attempts to make the case that the novel coronavirus couldnt have come from nature and instead may have been created by altering a previously discovered bat coronavirus. But several of its main points rest on faulty conclusions.
One of the studys main claims is that the genomic sequence of SARS-CoV-2 is suspiciously similar to that of a bat coronavirus discovered by military laboratories in China and therefore indicates that another coronavirus was used to create the novel coronavirus.
Kristian G. Andersen, a professor of immunology and microbiology at Scripps Research who has studied the origins of the virus, said of the claim on Twitter: This simply cant be true there are more than 3,500 nucleotide differences between SARS-CoV-2 and these viruses.
This content is imported from Twitter.You may be able to find the same content in another format, or you may be able to find more information, at their web site.
And Dr. Stanley Perlman, a professor of microbiology and immunology at the University of Iowa who studies coronaviruses, told us in an email that the coronavirus referenced ZC45 is only 89% related to SARS-CoV-2. In virology terms, that is very distant.
Perlman said it would be nearly impossible to make the reverse genetics system needed to manipulate the virus and changing its sequence to arrive at SARS-CoV-2 would be virtually impossible since it would not be known how to manipulate the virus.
Nevertheless, Dr. Li-Meng Yan one of the authors of the new paper and a virologist who has claimed she fled China to reveal the truth about COVID-19 doubled down on Carlsons show. She alleged a cover-up by the Chinese government and the scientific community.
The paper goes on to suggest that SARS-CoV-2 contains a unique furin-cleavage site in its Spike protein which is completely absent in this particular class of coronaviruses found in nature and that, therefore, the virus was engineered.
Susan R. Weiss, a University of Pennsylvania professor of microbiology who researches coronaviruses, told us in an email that that makes no sense in terms of what we know about coronaviruses.
Among murine coronavirus strains there are viruses with the furin site and strains without closely related strains closer than SARS-1 and SARS-2 yet they are all virulent, Weiss said. So this observation says nothing to me about the virus being engineered.
A furin site is a short protein sequence that can be recognized and cut by other proteins.
Perlman also said furin sites are found in many coronaviruses and finding it does not surprise us in the field.
The paper also argues a conspiracy is afoot by claiming that scientific journals wont publish the alternative theory that the virus may have come from a research laboratory.
I dont believe that, Weiss said. It is just that the data is not compelling. I dont know any CoV researchers that believe this at all. There is no way anyone could figure out how to make a virus behave like SARS-2 asymptomatic spread for [one] thing.
In March, Andersen and other scientists concluded in an article in Nature Medicine that the novel coronavirus is not a laboratory construct or a purposefully manipulated virus. The authors said that the virus likely originated in one of two ways: natural selection in an animal host before zoonotic transfer, meaning before the spread of disease from animals to humans, or natural selection in humans following zoonotic transfer.
The Nature Medicine article did say it couldnt rule out an accidental laboratory release of the naturally occurring virus, but its authors said they do not believe that any type of laboratory-based scenario is plausible.
The new, dubious paper attempts to discredit those findings by saying the Nature Medicine studys authors show signs of conflict of interests, raising further concerns on the credibility of this publication.
The supposed support for that allegation: that one of the authors, Columbia Universitys Dr. W. Ian Lipkin, received an award from China for his work on public health there following the 2003 outbreak of the coronavirus that causes severe acute respiratory syndrome, or SARS.
The new paper also references the curriculum vitae of another author Edward C. Holmes, a researcher at the University of Sydney in Australia which shows that he has collaborated with scientists and organizations in China.
[D]espite the online lies and malicious editing of my Wikipedia page, I have never received any funds from China, personal or research, and have no grants with Chinese scientists. I do have some honorary appointments there and a nice certificate though, Holmes wrote on Twitter. I do work closely with some Chinese scientists and as that directly led to the first release of the genome sequence that might just perhaps possibly be argued to be a good thing.
Andersen also said that the allegation about the authors being conflicted was wrong. [M]y lab has never received funding from China and we have no collaborations with Chinese investigators. I have no financial interests in China, he said in a tweet. All our analyses are scientific and unbiased.
Its worth noting that collaborations between researchers in the U.S. and China arent uncommon. A recent study published in Higher Education found that U.S. research output between 2014 and 2018 would have dropped without Chinese partnerships while Chinas output would have grown regardless of work with the U.S. [T]he findings demonstrate that the USA has more to lose than gain in cutting ties with China, its authors wrote.
Public health officials have also suggested the virus originated in bats.
The Centers for Disease Control and Prevention has said: The SARS-CoV-2 virus is a betacoronavirus, like MERS-CoV and SARS-CoV. All three of these viruses have their origins in bats. The sequences from U.S. patients are similar to the one that China initially posted, suggesting a likely single, recent emergence of this virus from an animal reservoir. However, the exact source of this virus is unknown.
And in April, the Office of the Director of National Intelligence said in a statement that the Intelligence Community also concurs with the wide scientific consensus that the COVID-19 virus was not manmade or genetically modified. The intelligence community, it said, will continue to rigorously examine emerging information and intelligence to determine whether the outbreak began through contact with infected animals or if it was the result of an accident at a laboratory in Wuhan.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told National Geographic in a May interview, If you look at the evolution of the virus in bats and whats out there now, [the scientific evidence] is very, very strongly leaning toward this could not have been artificially or deliberately manipulated.
Everything about the stepwise evolution over time strongly indicates that [this virus] evolved in nature and then jumped species, Fauci said.
Jessica McDonald contributed to this article.
Editors note: FactCheck.org is one of several organizations working with Facebook to debunk misinformation shared on social media. Our previous stories can be found here.
See original here:
Report resurrects false claim that coronavirus was bioengineered - WXII The Triad
- Inflation Reduction Act Projected to Impact Medicare Access to Immunology, Oncology, and Endocrinology Drugs in 2025 - geneonline.com - June 10th, 2025 [June 10th, 2025]
- Convocation 25: Adrien Lam, BSc Honors Immunology and Infection - University of Alberta - June 10th, 2025 [June 10th, 2025]
- Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off - R&D World - April 27th, 2025 [April 27th, 2025]
- Dr. Sabine Ehrt Named Chair of the Department of Microbiology and Immunology at Weill Cornell Medicine - WCM Newsroom - April 19th, 2025 [April 19th, 2025]
- RayThera launches with $110 million to advance immunology pipeline - The Pharma Letter - April 10th, 2025 [April 10th, 2025]
- Celebrate Vaccines: The legacy of the tetanus vaccine - British Society for Immunology - April 10th, 2025 [April 10th, 2025]
- Another immunology biotech emerges as Hillstar takes flight with $67M - Endpoints News - March 30th, 2025 [March 30th, 2025]
- Alumnus discovers passion for immunology, teaching at Mercer - Mercer University - March 15th, 2025 [March 15th, 2025]
- The future of immunology - Johnson & Johnson - March 5th, 2025 [March 5th, 2025]
- Immunotherapys Sweet Future: Wrapping up AACR IO 2025 With Glyco-immunology - American Association for Cancer Research (AACR) - March 5th, 2025 [March 5th, 2025]
- J&J receives three CHMP recommendations for immunology and oncology indications - PMLiVE - March 5th, 2025 [March 5th, 2025]
- Greater Austin Allergy, Asthma & Immunology now open in the Shops at the Galleria - Community Impact - March 5th, 2025 [March 5th, 2025]
- As dengue spreads, researchers discover a clue to fighting the virus - La Jolla Institute for Immunology - February 25th, 2025 [February 25th, 2025]
- Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress - Business... - February 25th, 2025 [February 25th, 2025]
- PhD candidate Jesse Lehman receives Kirschstein Award to study immunology - UMass Medical School - February 25th, 2025 [February 25th, 2025]
- Cross-priming in cancer immunology and immunotherapy - Nature.com - February 3rd, 2025 [February 3rd, 2025]
- Sanofi Happy To Spend To Hit Immunology Top Spot - News & Insights - February 3rd, 2025 [February 3rd, 2025]
- The Converging Therapeutic Landscape of Oncology and Immunology: Accelerating Innovation in Biotech - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- Immunology - The Scientist - January 23rd, 2025 [January 23rd, 2025]
- Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System - MedCity News - January 15th, 2025 [January 15th, 2025]
- Scipher Medicine and Atropos Health Partner to Accelerate Precision Medicine and Expand the Immunology Multimodal Network - Business Wire - December 23rd, 2024 [December 23rd, 2024]
- AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition - PMLiVE - December 23rd, 2024 [December 23rd, 2024]
- Sir Gustav Nossal Professor of Immunology to honour giant of Australian science - Walter and Eliza Hall Institute of Medical Research - December 9th, 2024 [December 9th, 2024]
- Research Assistant in Immunology - Surrey, United Kingdom job with UNIVERSITY OF SURREY | 384335 - Times Higher Education - November 28th, 2024 [November 28th, 2024]
- Reflecting on Pioneering organoids and 3D cell cultures for animal and human health - British Society for Immunology | - November 28th, 2024 [November 28th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire - November 20th, 2024 [November 20th, 2024]
- TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire - November 20th, 2024 [November 20th, 2024]
- Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today - November 20th, 2024 [November 20th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian - November 20th, 2024 [November 20th, 2024]
- Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of... - November 20th, 2024 [November 20th, 2024]
- What it's like in allergy and immunology: Shadowing Dr. Fraser - American Medical Association - November 12th, 2024 [November 12th, 2024]
- Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society - Newswire - November 12th, 2024 [November 12th, 2024]
- Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
- Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
- Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
- Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
- Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
- New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
- Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
- Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
- Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
- Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
- Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
- UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
- Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
- Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
- How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
- Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
- Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
- Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
- Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
- Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
- COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
- HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
- Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
- Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
- Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
- Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
- Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
- Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
- Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
- Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
- Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
- Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
- Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
- Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
- Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
- AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
- Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
- Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
- Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]